The role of hyperleptinaemia and low values of interleukin 10 in de novo DSA production after kidney transplantation

被引:0
|
作者
Dedinska, Ivana [1 ,2 ,3 ,5 ]
Kleinova, Patricia [1 ,2 ,3 ]
Machalekova, Katarina [4 ]
Granak, Karol [1 ,2 ,3 ]
Vnucak, Matej [1 ,2 ,3 ]
Beliancinova, Monika [1 ,2 ,3 ]
机构
[1] Univ Hosp Martin, Transplant Ctr, Martin, Slovakia
[2] Comenius Univ, Jessenius Fac Med, Bratislava, Slovakia
[3] Univ Hosp Martin, Dept Internal Dis 1, Martin, Slovakia
[4] St Elizabeth Canc Inst, Dept Pathol, Bratislava, Slovakia
[5] Univ Hosp Martin, Transplant Ctr, Kollarova 2, Martin 03601, Slovakia
关键词
Leptin; IL-10; Protocol biopsy; Kidney transplantation; LEPTIN LEVELS; BODY-FAT; POLYMORPHISMS; ADIPONECTIN; ACTIVATION; DISEASE; WEIGHT; IL-10; ALPHA; INDEX;
D O I
10.1016/j.trim.2023.101982
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: White adipose tissue secretes a number of peptide hormones. The aim of this paper was to determine the role of leptin, adiponectin and interleukin-10 and interleukin-6 on the development of graft rejection in protocol biopsy after kidney transplantation. Methods: In a prospective analysis (n = 104), we monitored the values of leptin, adiponectin, IL -6, and IL -10 prior to the transplantation and in the 3rd month after the transplantation. The protocol biopsy of the graft was performed in the 3rd month after the transplantation. The group was divided into the following according to the biopsy result: negative result, IFTA 1, borderline, and DSA positive. Results: After adjusting for the differences in the baseline recipient and donor characteristics, we identified the hyperleptinaemia baseline (HR = 2.0444, P = 0.0341) and month 3 (HR = 49.8043, P < 0.0001) as independent risk factors for borderline changes in the protocol biopsy. The hyperleptinaemia baseline (HR = 7.4979, P = 0.0071) and month 3 (HR = 9.7432, P = 0.0057) are independent risk factors for de novo DSA positivity. A low value of IL -10 month 3 is a risk factor for de novo DSA positivity (HR = 3.0746, P = 0.0388). Conclusions: Higher leptin levels and low values of IL -10 might play a role in rejection and de novo DSA production.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] De novo thrombotic microangiopathy after kidney transplantation in adults: Interplay between complement genetics and multiple endothelial injury
    Dessaix, Kathleen
    Bontoux, Christophe
    Aubert, Olivier
    Grunenwald, Anne
    Soussan, Rebecca Sberro
    Zuber, Julien
    Van Huyen, Jean-Paul Duong
    Anglicheau, Dany
    Legendre, Christophe
    Bacchi, Veronique Fremeaux
    Rabant, Marion
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (07) : 1205 - 1217
  • [22] The natural history of de novo donor-specific HLA antibodies after kidney transplantation
    Lopez del Moral, Covadonga
    Wu, Kaiyin
    Naik, Marcel
    Osmanodja, Bilgin
    Akifova, Aylin
    Lachmann, Nils
    Stauch, Diana
    Hergovits, Sabine
    Choi, Mira
    Bachmann, Friederike
    Halleck, Fabian
    Schrezenmeier, Eva
    Schmidt, Danilo
    Budde, Klemens
    FRONTIERS IN MEDICINE, 2022, 9
  • [23] Risk Factors for De Novo Malignancies in Women After Kidney Transplantation A Multicenter Transversal Study
    Helmy, Samir
    Marschalek, Julian
    Bader, Yvonne
    Koch, Marianne
    Schmidt, Alice
    Kanzler, Marina
    Gyoeri, Georg
    Polterauer, Stephan
    Reinthaller, Alexander
    Grimm, Christoph
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (05) : 967 - 970
  • [24] De novo gastrointestinal tumours after renal transplantation:: Role of CMV and EBV viruses
    Adani, GL
    Baccarani, U
    Lorenzin, D
    Gropuzzo, M
    Tulissi, P
    Montanaro, D
    Currö, G
    Sainz, M
    Risaliti, A
    Bresadola, V
    Bresadola, F
    CLINICAL TRANSPLANTATION, 2006, 20 (04) : 457 - 460
  • [25] De novo congestive heart failure after kidney transplantation: A common condition with poor prognostic implications
    Lentine, KL
    Schnitzler, MA
    Abbott, KC
    Li, LM
    Burroughs, TE
    Irish, W
    Brennan, DC
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (04) : 720 - 733
  • [26] De Novo Donor-Specific Human Leukocyte Antigen Antibodies Early After Kidney Transplantation
    Heilman, Raymond L.
    Nijim, Ala
    Desmarteau, Yvonne M.
    Khamash, Hasan
    Pando, Marcelo Jorge
    Smith, Maxwell L.
    Chakkera, Harini A.
    Huskey, Janna
    Valdez, Riccardo
    Reddy, Kunam Sudhakar
    TRANSPLANTATION, 2014, 98 (12) : 1310 - 1315
  • [27] De novo lupus-like glomerulonephritis after pediatric non-kidney organ transplantation
    Farkas-Skiles, Cristina M.
    Ettenger, Robert B.
    Zuckerman, Jonathan E.
    Pearl, Meghan
    Venick, Robert S.
    Weng, Patricia L.
    PEDIATRIC NEPHROLOGY, 2022, 37 (01) : 153 - 161
  • [28] Characteristics of mismatched eplets affecting de novo donor-specific antibody production and antibody-mediated rejection after kidney transplantation
    Li, Mei-He
    Zhou, Gu-Xiang
    Lan, Ping
    Li, Yi-Xuan
    Zhang, Xuan
    Kuang, Pei-Dan
    Zhang, Ying
    Wang, Ying
    Zhang, Min-Yue
    Ding, Xiao-Ming
    Xue, Wu-Jun
    Zheng, Jin
    BMC NEPHROLOGY, 2025, 26 (01)
  • [29] Everolimus With Very Low-Exposure Cyclosporine A in De Novo Kidney Transplantation: A Multicenter, Randomized, Controlled Trial
    Salvadori, Maurizio
    Scolari, Maria Piera
    Bertoni, Elisabetta
    Citterio, Franco
    Rigotti, Paolo
    Cossu, Maria
    Dal Canton, Antonio
    Tisone, Giuseppe
    Albertazzi, Alberto
    Pisani, Francesco
    Gubbiotti, Giampiero
    Piredda, Gianbenedetto
    Busnach, Ghil
    Sparacino, Vito
    Goepel, Volker
    Messa, Piergiorgio
    Berloco, Pasquale
    Montanaro, Domenico
    Veroux, Pierfrancesco
    Federico, Stefano
    Bartezaghi, Marta
    Corbetta, Giuseppe
    Ponticelli, Claudio
    TRANSPLANTATION, 2009, 88 (10) : 1194 - 1202
  • [30] Case report: Early onset de novo FSGS in a child after kidney transplantation-a successful treatment
    Abreu, Karla Carvajal
    Loos, Sebastian
    Fischer, Lutz
    Pape, Lars
    Wiech, Thorsten
    Kemper, Markus J.
    Toenshoff, Burkhard
    Oh, Jun
    Schild, Raphael
    FRONTIERS IN PEDIATRICS, 2023, 11